FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doxepin 10mg capsules (A A H Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Weleda Relaxing oral drops (Weleda (UK) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 250,000unit powder for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Aymes Acusist Clear Instant Thickener powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Questran 4g oral powder sachets (Neon Healthcare Ltd) 50 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracycline 250mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hamamelis liquid extract 81.54% gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ongavia 2.3mg/0.23ml solution for injection vials (Teva UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metformin 500mg oral powder sachets sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hamamelis liquid extract 81.54% gel 50 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Witch Doctor gel (Robinson Young Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Boots Witch Hazel gel (The Boots Company) 50 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for concentrate for solution for infusion vials (Sovereign Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hamamelis liquid extract 81.54% gel 35 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metformin 500mg oral powder sachets sugar free (A A H Pharmaceuticals Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ongavia 2.3mg/0.23ml solution for injection vials (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Boots Witch Hazel gel (The Boots Company) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for concentrate for solution for infusion vials (Sovereign Medical Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Witch Doctor gel (Robinson Young Ltd) 35 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apple mistletoe 20mg/1ml with Mercuric sulphate solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iscador M c Hg 20mg/1ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iscador M c Hg 20mg/1ml solution for injection ampoules (Weleda (UK) Ltd) 7 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apple mistletoe 20mg/1ml with Mercuric sulphate solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apple mistletoe 20mg/1ml with Mercuric sulphate solution for injection ampoules 7 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iscador M c Hg 20mg/1ml solution for injection ampoules (Weleda (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iscador M c Hg 20mg/1ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iscador M c Hg 20mg/1ml solution for injection ampoules (Weleda (UK) Ltd) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Zentiva Pharma UK Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Zentiva Pharma UK Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (J M Loveridge Plc) 25 kg VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium bicarbonate 8.4% (1mmol/ml) solution for infusion 100ml bottles (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax 500 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (J M Loveridge Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax 20 kg VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (Unichem Plc) 500 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (J M Loveridge Plc) 500 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (A A H Pharmaceuticals Ltd) 500 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium bicarbonate 8.4% (1mmol/ml) solution for infusion 100ml bottles (B.Braun Medical Ltd) 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax 25 kg VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (Unichem Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Emulsifying wax (J M Loveridge Plc) 20 kg VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vitis compound tablets (Weleda (UK) Ltd) 200 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml solution for infusion bottles (Kent Pharma (UK) Ltd) 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Plumbum mellitum 12x homeopathic tablets 180 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Scleron 12x homeopathic tablets (Weleda (UK) Ltd) 180 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Vitis compound tablets 200 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Honey 1.76% / Menthol 0.076% pastilles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Cerumol ear drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Throaties Blackcurrant pastilles (Ernest Jackson & Co. Ltd) 10 pastille VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Honey 1.76% / Menthol 0.076% pastilles 10 pastille VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Throaties Blackcurrant pastilles (Ernest Jackson & Co. Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 0.9% irrigation solution 45ml unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes 10 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Aguettant Ltd) 10 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 0.9% irrigation solution 45ml unit dose 24 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MiniVersol sodium chloride 0.9% irrigation solution 45ml unit dose (Aguettant Ltd) 24 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MiniVersol sodium chloride 0.9% irrigation solution 45ml unit dose (Aguettant Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Aguettant Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet lidocaine 100mg/10ml (1%) solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pemetrexed 1g/40ml concentrate for solution for infusion vials (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pemetrexed 100mg/4ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets (Special Order) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nadolol 40mg tablets (Part VIIID Drug Tariff Special Order) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pemetrexed 500mg/20ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pemetrexed 500mg/20ml concentrate for solution for infusion vials (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrochlorothiazide 25mg tablets (Part VIIID Drug Tariff Special Order) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tears Naturale II eye drops (Alcon Eye Care UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 10mg tablets (Part VIIID Drug Tariff Special Order) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Healthcare Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (Part VIIID Drug Tariff Special Order) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (Part VIIID Drug Tariff Special Order) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tears Naturale eye drops (Alcon Eye Care UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets (Special Order) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrochlorothiazide 25mg tablets (Part VIIID Drug Tariff Special Order) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrochlorothiazide 25mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Aymes Acusist Clear Instant Thickener powder 126 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 10mg tablets (Part VIIID Drug Tariff Special Order) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tears Naturale II eye drops (Alcon Eye Care UK Ltd) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrochlorothiazide 25mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Megestrol 40mg tablets (Part VIIID Drug Tariff Special Order) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Danazol 100mg capsules (Part VIIID Drug Tariff Special Order) 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Healthcare Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Part VIIID Drug Tariff Special Order) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aymes Acusist Clear Instant Thickener powder (Aymes International Ltd) 126 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tears Naturale eye drops (Alcon Eye Care UK Ltd) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 14 of 86 Next End


This concept is not in any reference sets

Back to Start